These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34065377)

  • 1. Discovery of Novel eEF2K Inhibitors Using HTS Fingerprint Generated from Predicted Profiling of Compound-Protein Interactions.
    Yoshimori A; Kawasaki E; Murakami R; Kanai C
    Medicines (Basel); 2021 May; 8(5):. PubMed ID: 34065377
    [No Abstract]   [Full Text] [Related]  

  • 2. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
    Liu R; Proud CG
    Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
    Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
    Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
    Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
    Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy.
    Pan Z; Chen Y; Liu J; Jiang Q; Yang S; Guo L; He G
    Eur J Med Chem; 2018 Jan; 144():517-528. PubMed ID: 29288948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors.
    Xiao T; Liu R; Proud CG; Wang MW
    Acta Pharm Sin B; 2016 Nov; 6(6):557-563. PubMed ID: 27818922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability.
    Laufkötter O; Sturm N; Bajorath J; Chen H; Engkvist O
    J Cheminform; 2019 Aug; 11(1):54. PubMed ID: 31396716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico, synthesis and anticancer evaluation of benzamide tryptamine derivatives as novel eEF2K inhibitors.
    Liu Z; Jiang A; Wang Y; Xu P; Zhang Q; Wang Y; He S; Wang N; Jin H; Zhang B
    Bioorg Med Chem Lett; 2022 Jul; 67():128759. PubMed ID: 35483594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.
    Zhang B; Zou J; Zhang Q; Wang Z; Wang N; He S; Zhao Y; Naman CB
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors of eukaryotic elongation factor 2 kinase: In silico, synthesis and in vitro studies.
    Onder FC; Durdagi S; Kahraman N; Uslu TN; Kandemir H; Atici EB; Ozpolat B; Ay M
    Bioorg Chem; 2021 Nov; 116():105296. PubMed ID: 34488125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
    Beretta S; Gritti L; Verpelli C; Sala C
    Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy.
    Comert Onder F; Siyah P; Durdagi S; Ay M; Ozpolat B
    RSC Med Chem; 2022 Jul; 13(7):840-849. PubMed ID: 35923718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGBVS-DNN: Prediction of Compound-protein Interactions Based on Deep Learning.
    Hamanaka M; Taneishi K; Iwata H; Ye J; Pei J; Hou J; Okuno Y
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27515489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
    Fu LL; Xie T; Zhang SY; Liu B
    Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of New Inhibitors of eEF2K from Traditional Chinese Medicine Based on In Silico Screening and In Vitro Experimental Validation.
    Fu Q; Liu X; Li Y; Wang P; Wu T; Xiao H; Zhao Y; Liao Q; Song Z
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
    Bianco C; Thompson L; Mohr I
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts.
    Kameshima S; Okada M; Yamawaki H
    Apoptosis; 2019 Apr; 24(3-4):359-368. PubMed ID: 30737648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes.
    Kameshima S; Okada M; Ikeda S; Watanabe Y; Yamawaki H
    Biochem Biophys Rep; 2016 Sep; 7():218-224. PubMed ID: 28955910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.
    Wang X; Xie J; Proud CG
    Cancers (Basel); 2017 Nov; 9(12):. PubMed ID: 29186827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
    Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
    Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.